)
But it?s nothing to cheer about as slowdown is secular and next two quarters may be worse
Domestic biz disappoints, as slowing demand hits operating margins
M&M surprises positively on margins & profit in Q1 as costs slip sequentially
Select analysts turn bullish, as unregulated businesses might drive 90% of incremental Ebitda over FY12-17
Three bad accounts in power, pharma and construction ratchet up fresh slippages to Rs 10,800 crore in Q1
Overcapacity and fear of Chinese exports may keep steel prices depressed
Better earnings visibility drive foreign institutions to bet on the country
While the bulls are charged by resilience in earnings growth, it¿s difficult to wish away macro challenges
Apart from concentration of risk, investors worried over weak cash flows
Profit beat of most Sensex and Nifty companies come in above estimates
Given the pace at which the company is resuming operations at Manesar, the market expects negligible volume loss
Top brokerages are finding the Sensex fully valued and stock-picking difficult
Growth momentum to be driven by launches in the US, domestic market
Buy pharma, consumer and utilities sell banking, industrials and energy
If Cairn gets nod to explore producing fields in Rajasthan, output could jump
Strong volume growth, better realisations and a firm handle on costs made it stand out in the cement pack
As several refineries shut globally, capacity constraints raised margins